Loading clinical trials...
Loading clinical trials...
Conditions
Interventions
Subjects previously implanted with INSPIRIS RESILIA Model 11500A and are undergoing planned valve-in-valve treatment.
Locations
7
United States
University of Southern California
Los Angeles, California, United States
University of Florida
Gainesville, Florida, United States
AdventHealth Orlando
Orlando, Florida, United States
St. Vincent Hospital
Indianapolis, Indiana, United States
Nyph/Cumc
New York, New York, United States
The Cleveland Clinic Foundation
Cleveland, Ohio, United States
Start Date
June 1, 2028
Primary Completion Date
December 1, 2030
Completion Date
January 1, 2031
Last Updated
September 2, 2025
NCT07365345
NCT06518317
NCT04139616
NCT05539937
NCT07045233
NCT05202977
Lead Sponsor
Edwards Lifesciences
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions